Clinical Trial Search

Primary: Number of Participants With Pregnancy in Loop-shaped Intrauterine Device Group and Intrauterine Balloon Group — 12; 22 participants — p=0.009

Primary: Number of Participants With Adhesion Reformation (American Fertility Society Score of Greater Than 0) 8 Weeks Later After the Index Surgery — 21; 38 Participants — p=0.012

Primary: Safety (Adverse Events) — 0 device related adverse event

Primary: the AFS Score at Second-look Hysteroscopy — 6.5; 8 Units on a scale — p=<0.05

Primary: the AFS Score at Second-look Hysteroscopy — 1.6; 1.9 units on a scale — p=>0.05

Primary: Number of Participants With Absence of Newly Formed Intrauterine Adhesions Following RF Ablation of Fibroids — 34 Participants

Primary: Chemical Pregnancy Rate — 40; 19 participants

Primary: Measurement of Uterine Artery Pulsatility Index — 2.40; 2.35 index — p=<0.05

Primary: Number of Participants With Uterine Artery Indices Completed — 13; 3 Participants

Primary: The Zung Self-Rating Anxiety Scale Scores Before and After the Intervention — 36.4; 37.3; 32.1; 38.5 units on a scale(raw scores) — p=<0.001

Primary: Successful Retention of IUD — 7 participants

Primary: Rates of Uterine Perforation — 0 Number of cases

Primary: Uterine Perforation Rate — 61; 20 participants

Primary: Expulsion Rate — 9 participants

Primary: Loss of the Retro Placental Sonolucent Zone by 2D Grayscale Ultrasonography — 12; 19 participants

Primary: IUD Expulsion — 11 Participants

Primary: Percentage of Women With Expulsion of an Intrauterine Device (IUD) Placed After Medical Abortion. — 4 percentage of participants

Primary: Patient-perceived Pain — 3; 4 score on a scale — p=0.21

Primary: Intrauterine Fluid Volume Lost — 2.2; 7.8 ml

Primary: Pain With Intrauterine Device (IUD) Placement — 54; 33 mm

Primary: The Primary Outcome is LNG-IUD Usage Six Months Following Enrollment. — 85.2; 62.9 percentage of participants — p=0.05

Primary: Clinical Pregnancy Rate

Primary: Number of Participants With Expulsion of IUD — 54; 0 Participants

Primary: The Ease of IUD Insertion as Rated by the Provider Using a 100mm Visual Analog Scale (VAS). — 24; 29 mm

Primary: Serum Level of TNF-alfa,IL-10, for All Participants in Three Study Group at Day of Ova Pickup Compared to That at Day of Embryo Transfer — 43.56; 41.59; 40.94; 30.33 pg/ml

Primary: Patient Perceived Pain on a 100-point Visual Analogue Scale. — 0.5; 0.8; 5.8; 5.9 units on a scale

Primary: Provider Perceived Ease of Insertion on a 100-point Visual Analogue Scale (VAS) — 25.1; 27.4 units on a scale — p=0.64

Primary: Post-operative Evidence of Adenomyoma Tissue Ablation Effect by Area (n) as Assessed by Pathological Analysis — 9; 8; 7; 6 treated areas

Primary: Use of the IUD for Contraception at Six Months — 49; 51 participants — p=0.24

Primary: Number of Patients With Adhesions to Uterine Scars — 12; 24 participants